S
20.32
0.58 (2.94%)
| 前收盘价格 | 19.74 |
| 收盘价格 | 19.77 |
| 成交量 | 2,330,166 |
| 平均成交量 (3个月) | 2,705,780 |
| 市值 | 1,766,109,568 |
| 价格/销量 (P/S) | 14.61 |
| 股市价格/股市净资产 (P/B) | 14.15 |
| 52周波幅 | |
| 利润日期 | 3 Nov 2025 |
| 营业利益率 (TTM) | -416.67% |
| 稀释每股收益 (EPS TTM) | -3.85 |
| 总债务/股东权益 (D/E MRQ) | 160.71% |
| 流动比率 (MRQ) | 5.80 |
| 营业现金流 (OCF TTM) | -286.52 M |
| 杠杆自由现金流 (LFCF TTM) | -169.65 M |
| 资产报酬率 (ROA TTM) | -36.29% |
| 股东权益报酬率 (ROE TTM) | -93.70% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Syndax Pharmaceuticals, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-0.2
| 分析师共识 | 3.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -5.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.20 |
|
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 1.29% |
| 机构持股比例 | 120.71% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 56.00 (BTIG, 175.59%) | 购买 |
| 中 | 39.00 (91.93%) | |
| 低 | 33.00 (JP Morgan, 62.40%) | 购买 |
| 平均值 | 41.00 (101.77%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 15.64 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Barclays | 24 Nov 2025 | 35.00 (72.24%) | 购买 | 19.76 |
| 04 Nov 2025 | 22.00 (8.27%) | 购买 | 15.35 | |
| JP Morgan | 12 Nov 2025 | 33.00 (62.40%) | 购买 | 16.79 |
| UBS | 04 Nov 2025 | 38.00 (87.01%) | 购买 | 15.35 |
| BTIG | 27 Oct 2025 | 56.00 (175.59%) | 购买 | 13.11 |
| 19 Sep 2025 | 56.00 (175.59%) | 购买 | 14.78 | |
| HC Wainwright & Co. | 27 Oct 2025 | 40.00 (96.85%) | 购买 | 13.11 |
| 16 Oct 2025 | 40.00 (96.85%) | 购买 | 15.05 | |
| Stifel | 10 Sep 2025 | 44.00 (116.54%) | 购买 | 15.73 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| GOLDAN KEITH A. | - | 19.12 | -1,224 | -23,403 |
| 累积净数量 | -1,224 | |||
| 累积净值 ($) | -23,403 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 19.12 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| GOLDAN KEITH A. | 职员 | 01 Dec 2025 | 处理 (-) | 1,224 | 19.12 | 23,403 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合